SCHEMBL8378580

SCHEMBL8378580

C[CH]N(CCCCCCCCCCCC)CCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 6/20 0.50
TSHR P16473 4/20 0.44
THRB P10828 1/20 0.44
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
GBA1 P04062 1/20 0.37
MGLL Q99685 1/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290987 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL8375292 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL8377127 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL8375332 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL8377234 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL3248571 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL4392237 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL8374767 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL8379911 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1
SCHEMBL292544 1.00 DNM1 (0.50) DNM1TSHRTHRBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 CN disclosed
CN-118234707-A Cyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-06-21 CN disclosed
US-20240024422-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2024-01-25 US disclosed
EP-4186518-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ModernaTX, Inc. (US) 2023-05-31 EP disclosed
US-11571463-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2023-02-07 US disclosed
US-11311602-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2022-04-26 US disclosed
US-20210299221-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2021-09-30 US disclosed
US-11000573-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2021-05-11 US disclosed
US-20200376081-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF MODERNATX, INC. 2020-12-03 US disclosed
US-10646549-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof MODERNATX, INC. (US) 2020-05-12 US disclosed
US-20190125839-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2019-05-02 US disclosed
EP-3458083-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF Modernatx, Inc. (US) 2019-03-27 EP disclosed
WO-2017201350-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF MODERNATX, INC. (US) 2017-11-23 WO disclosed
US-5986042-A Cross-linked polymer MITSUI CHEMICALS, INC. (JP) 1999-11-16 US disclosed
EP-0856539-A1 Cross-linked polymer Mitsui Chemicals, Inc. (JP) 1998-08-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11571463-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-11311602-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20210299221-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-10646549-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20200376081-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20240024422-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-11000573-B2 Polynucleotides encoding interleukin-12 (IL12) and uses thereof IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885
US-20190125839-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF IL2, IL15, RBM12 DNM1 3573/4885TSHR 3940/4885THRB 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.